Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

The document concluded that stem cells are crucial for skin repair, regeneration, and may help in developing advanced skin substitutes.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The document explains how sperm cells are produced, the role of testosterone in this process, and how toxins can reduce sperm count and fertility.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

COVID-19 doesn't make alopecia areata worse.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Tinea capitis can be misdiagnosed as bacterial infection in adult women but is treatable with antifungal medication.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.